Atricure Inc. buy JPMorgan Chase & Co.
Start price
11.02.25
/
50%
€29.29
Target price
11.02.26
€49.31
Performance (%)
-9.87%
End price
12.02.26
€26.40
Summary
This prediction ended on 12.02.26 with a price of €26.40. With a performance of -9.87%, the BUY prediction for Atricure Inc. by JPMorgan_Chase___Co_ closed slightly in the red. JPMorgan_Chase___Co_ has a follow-up prediction for Atricure Inc. where he still thinks Atricure Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | 8.065% | 8.065% | -35.161% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $40.00 to $51.00. They now have an "overweight" rating on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten